GE HealthCare hangs a new AI-powered cath lab system from the ceiling

GE HealthCare on Sunday, Nov. 1, 2026, introduced Allia Celeo, a ceiling-mounted image-guiding system for cardiology and interventional radiology suites, at the TCT 2026 conference in San Diego. The pitch: fewer interruptions mid-procedure and an AI-driven image chain that adjusts settings automatically to keep image quality consistent at the lowest dose.

Cath labs are expensive rooms where minutes matter and every image costs the patient (and the staff) some radiation. GE's bet is that AI earns its keep here not with a flashy diagnosis but by quietly tuning dose and image quality in the background so nobody has to fiddle mid-procedure. That's the less glamorous, more believable version of medical AI. The catch is in the footnote: no dose numbers yet, and no FDA clearance, so for now this is a European product with an American trade-show booth.

GE HealthCare (Nasdaq: GEHC) introduced Allia Celeo at the Transcatheter Cardiovascular Therapeutics conference, TCT 2026, in San Diego. It is a ceiling-mounted image-guiding system for interventional suites that move a lot of patients through many kinds of procedures, aimed at cardiology and interventional radiology teams. Those lines are the company's Nov. 1 press release.

The hardware is built to stay out of the team's way. A slim, symmetrical ceiling gantry, the moving frame overhead, carries its cabling with it so more of the floor stays clear. The bore, the opening the arm has to swing through, is extra wide, so the C-arm can rotate freely and still reach steep angles for a patient with a high BMI. BMI is a height-and-weight number; here it means a larger patient. A C-arm is the curved piece that holds the X-ray source on one end and the detector on the other. GE says both the arm and the detector are thin enough that people on opposite sides of the table can see each other. Fast panning along the ceiling, and a table that covers more of the body, are there for head-to-toe imaging. Those details are GE's.

InnovaBreeze uses automatic table and gantry movements to capture the full lower-limb anatomy in a single acquisition, one pass instead of a string of repositioned shots. People in the room can adjust the gantry and the table from more than one spot, and an on-screen digital twin, a software preview of the hardware, shows the position before the real machine moves. Those features are GE's.

The AI piece is the image chain, the path from the X-ray exposure to the picture on the monitor. GE says features in that chain adjust the acquisition settings on their own, with the goal of consistent image quality at the lowest dose, for both flat 2D pictures and 3D volumes. Dose, here, is how much radiation the shot uses. The same system can render cardiac images in one click, matched to the way each operator likes to see them. The release describes the aim. It does not give a dose-reduction percentage, and it does not give clinical results for Celeo. Those lines, and that gap, are GE's.

Celeo works with OnWatch Predict, GE's 24/7 remote monitoring. Deep learning, software that looks for patterns in machine data, is meant to spot trouble before an unplanned shutdown. The system also works with tools already used in these rooms: StentViz and 3DStent, Valve ASSIST 2, the Mac-Lab hemodynamic system with FFR and dPR, Embo ASSIST AI, Vessel ASSIST, Needle ASSIST, the Vscan Air handheld ultrasound, and compatible third-party systems that image inside vessels or measure physiology. FFR, fractional flow reserve, is a pressure check on whether a narrowed artery is limiting blood flow. dPR, the diastolic pressure ratio, is a related check. That compatibility list is GE's.

This is the second new Allia system in less than a year. The earlier one, Allia Moveo, stands on the floor. Celeo hangs from the ceiling. That comparison is GE's.

Jyoti Gera, CEO of GE HealthCare's CardioVascular and Interventional Solutions and Advanced Imaging Solutions, said: "Every interventional suite has its own rhythm, and care teams need a system that adapts to the way they work rather than the other way around." Kat Davis, general manager, Interventional Solutions, said "a procedure should move at the pace of the care team, not the equipment." Those quotations are theirs, in the release.

Allia Celeo is CE marked, the European mark that lets a device be sold there. In the United States the 510(k) is still pending at the FDA. A 510(k) is the filing that asks to sell a device by showing it is close enough to one already cleared. Pending means that review is not finished. GE says the system is not available for sale in the United States, and that it may not be available in every region. The release does not list a price.

The picture is GE HealthCare's Allia Celeo: a white ceiling-mounted C-arm gantry on overhead rails beside a patient table, with a ceiling-hung monitor showing coronary angiography images, on a black background. Coronary angiography is an X-ray picture of the heart's arteries. The credit is GE HealthCare. It is the product image from the launch release.

In plain terms, GE HealthCare showed a ceiling-hung X-ray system for cath labs and interventional radiology, with software that is supposed to set the picture and the radiation dose without someone stopping to tweak it. Europe can sell it. The United States cannot, while the FDA review is still open. GE has not said how much dose it saves.